Colgate-Palmolive (NYSE:CL) insider Mukul Deoras sold 7,150 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $70.03, for a total value of $500,714.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Colgate-Palmolive (NYSE:CL) traded down $0.68 during trading on Wednesday, hitting $69.62. 3,579,222 shares of the stock traded hands, compared to its average volume of 4,417,115. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. Colgate-Palmolive has a fifty-two week low of $67.52 and a fifty-two week high of $77.91. The stock has a market cap of $61,460.00, a PE ratio of 30.54, a P/E/G ratio of 2.60 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting the consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the company posted $0.75 EPS. Colgate-Palmolive’s revenue was up 4.6% on a year-over-year basis. research analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current year.
Several equities analysts have weighed in on the stock. Citigroup lifted their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 30th. BNP Paribas cut shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Jefferies Group reiterated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 26th. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, November 1st. Finally, KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $77.71.
Several institutional investors have recently bought and sold shares of the company. Jacobi Capital Management LLC boosted its holdings in Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Virtue Capital Management LLC bought a new stake in Colgate-Palmolive in the fourth quarter worth $104,000. Krilogy Financial LLC boosted its holdings in Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Captrust Financial Advisors bought a new stake in Colgate-Palmolive in the second quarter worth $122,000. Finally, AlphaMark Advisors LLC boosted its holdings in Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares in the last quarter. Institutional investors and hedge funds own 72.85% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Insider Selling: Colgate-Palmolive (CL) Insider Sells 7,150 Shares of Stock” was first reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/14/insider-selling-colgate-palmolive-cl-insider-sells-7150-shares-of-stock.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.